Mutations in the endosomal ESCRTIII-complex subunit CHMP2B in frontotemporal dementia

Skibinski, Gaia, Parkinson, Nicholas J, Brown, Jeremy M, Chakrabarti, Lisa, Lloyd, Sarah L, Hummerich, Holger, Nielsen, Jørgen E, Hodges, John R +11 more·2005·Nature Genetics
DOI 10.1038/ng1609

Cited by (818)

Items 401–500 of 818

  1. Delineating the relationship between amyotrophic lateral sclerosis and frontotemporal dementia: Sequence and structure-based predictions
    Vijay Kumar, Asimul Islam, Md. Imtaiyaz Hassan, Faizan Ahmad · 2016 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
  2. Early microgliosis precedes neuronal loss and behavioural impairment in mice with a frontotemporal dementia-causing CHMP2B mutation
    Clayton, Emma L, Mancuso, Renzo, Nielsen, Troels Tolstrup, Mizielinska, Sarah, Holmes, Holly, Powell, Nicholas, Norona, Frances, Overgaard Larsen, Jytte, Milioto, Carmelo, Wilson, Katherine M. et al. · 2017 · Human Molecular Genetics
  3. Rare nonsynonymous variants in SORT1 are associated with increased risk for frontotemporal dementia
    Stéphanie Philtjens, Sara Van Mossevelde, Julie van der Zee, Eline Wauters, Lubina Dillen, Mathieu Vandenbulcke, Rik R. Vandenberghe, Adrian Ivanoiu, Anne Sieben, Christiana Willems et al. · 2018 · Neurobiology of Aging
  4. CHMP2B mutations are rare in French families with frontotemporal lobar degeneration
    Mustapha Ghanim, Léna Guillot‐Noël, Florence Pasquier, Ludmila Jornéa, Vincent Deramecourt, Bruno Dubois, Isabelle Le Ber, Alexis Brice · 2010 · Journal of Neurology
  5. The ESCRT-III protein VPS4, but not CHMP4B or CHMP2B, is pathologically increased in familial and sporadic ALS neuronal nuclei
    Alyssa N. Coyne, Jeffrey D. Rothstein · 2021 · Acta Neuropathologica Communications
  6. Genetic Diversity in Frontotemporal Dementia
    Yu. A. Shpilyukova, E. Yu. Fedotova, Sergey Nikolaevich Illarioshkin · 2020 · Molecular Biology
  7. AMSH is required to degrade ubiquitinated proteins in the central nervous system
    Shunya Suzuki, Keiichi Tamai, Masahiko Watanabe, Masanao Kyuuma, Masao Ono, Kazuo Sugamura, Nobuyuki Tanaka · 2011 · Biochemical and Biophysical Research Communications
  8. Cortical volumes and atrophy rates in FTD-3 CHMP2B mutation carriers and related non-carriers
    Simon Fristed Eskildsen, Lasse Riis Østergaard, Anders Bertil Rodell, Leif Østergaard, Jørgen Erik Nielsen, Adrian M. Isaacs, Peter Johannsen · 2008 · NeuroImage
  9. Neuronal Functions of ESCRTs
    Jin‐A Lee, Fen‐Biao Gao · 2012 · Experimental Neurobiology
  10. Alix and ALG-2 make a link between endosomes and neuronal death
    Anne‐Laure Mahul‐Mellier, Flavie Strappazzon, Christine Chatellard, Béatrice Blot, David M. Beal, Sakina Torch, Fiona J. Hemming, Anne Petiot, Jean‐Marc Verna, Sandrine Fraboulet et al. · 2009 · Biochemical Society Transactions
  11. Suberoylanilide hydroxamic acid increases progranulin production in iPSC-derived cortical neurons of frontotemporal dementia patients
    Sandra Almeida, Fuying Gao, Giovanni Coppola, Fen‐Biao Gao · 2016 · Neurobiology of Aging
  12. Promising therapies for the treatment of frontotemporal dementia clinical phenotypes: from symptomatic to disease-modifying drugs
    Giancarlo Logroscino, Bruno Pietro Imbimbo, Madia Lozupone, Rodolfo Sardone, Rosa Capozzo, Petronilla Battista, Chiara Zecca, Vittorio Dibello, Gianluigi Giannelli, Antonello Bellomo et al. · 2019 · Expert Opinion on Pharmacotherapy
  13. Modelling frontotemporal dementia using patient-derived induced pluripotent stem cells
    Georgie Lines, Jackie M. Casey, Elisavet Preza, Selina Wray · 2020 · Molecular and Cellular Neuroscience
  14. Biological Spectrum of Amyotrophic Lateral Sclerosis Prions
    Magdalini Polymenidou, Don W. Cleveland · 2017 · Cold Spring Harbor Perspectives in Medicine
  15. CHMP2B regulates TDP-43 phosphorylation and cytotoxicity independent of autophagy via CK1
    Xue Deng, Xing Sun, Wenkai Yue, Yongjia Duan, Rirong Hu, Kai Zhang, Jiangxia Ni, Jihong Cui, Qiangqiang Wang, Yelin Chen et al. · 2021 · The Journal of Cell Biology
  16. ESCRT, autophagy, and frontotemporal dementia
    Jin‐A Lee, Fen‐Biao Gao · 2008 · BMB Reports
  17. A network of RNA and protein interactions in Fronto Temporal Dementia
    Francesca Fontana, Kavitha Siva, Michela A. Denti · 2015 · Frontiers in Molecular Neuroscience
  18. Role of Progranulin as a Biomarker for Alzheimer's Disease
    Kristel Sleegers, Nathalie Brouwers, Christine Van Broeckhoven · 2010 · Biomarkers in Medicine
  19. How neurons maintain their axons long-term: an integrated view of axon biology and pathology
    Gaynor Ann Smith, Sean T. Sweeney, Cahir J. O’Kane, Andreas Prokop · 2023 · Frontiers in Neuroscience
  20. Exosome release from infected dendritic cells: A clue for a fast spread of prions in the periphery?
    Peter‐Christian Klöhn, Rocio Castro Seoane, John Collinge · 2013 · Journal of Infection
  21. Vps34 regulates myofibril proteostasis to prevent hypertrophic cardiomyopathy
    Hirotaka Kimura, Satoshi Eguchi, Junko Sasaki, Keiji Kuba, Hiroki Nakanishi, Shunsuke Takasuga, Masakazu Yamazaki, Akiteru Goto, Hiroyuki Watanabe, Hiroshi Itoh et al. · 2017 · JCI Insight
  22. Alzheimer's Disease and Frontotemporal Dementia: A Review of Pathophysiology and Therapeutic Approaches
    Sally Kelliny, Xin‐Fu Zhou, Larisa Bobrovskaya · 2025 · Journal of Neuroscience Research
  23. Endosomal sorting related protein CHMP2B is localized in Lewy bodies and glial cytoplasmic inclusions in α-synucleinopathy
    Satoshi Tanikawa, Fumiaki Mori, Kunikazu Tanji, Akiyoshi Kakita, Hitoshi Takahashi, Koichi Wakabayashi · 2012 · Neuroscience Letters
  24. Synaptopathy: presynaptic convergence in frontotemporal dementia and amyotrophic lateral sclerosis
    Emma L. Clayton, Laura Huggon, Michael Alan Cousin, Sarah Mizielinska · 2024 · Brain
  25. Preliminary Evidence that VEGF Genetic Variability Confers Susceptibility to Frontotemporal Lobar Degeneration
    Barbara Borroni, Serena Ghezzi, C. Agosti, Silvana Archetti, Chiara Fenoglio, Daniela Galimberti, Elio Angelo Scarpini, Mónica Di Luca, Nereo Bresolin, Giacomo P. Comi et al. · 2008 · Rejuvenation Research
  26. Clinical variability and onset age modifiers in an extended Belgian GRN founder family
    Eline Wauters, Sara Van Mossevelde, Kristel Sleegers, Julie van der Zee, Sebastiaan Engelborghs, Anne Sieben, Rik R. Vandenberghe, Stéphanie Philtjens, Marleen Van den Broeck, Karin Peeters et al. · 2018 · Neurobiology of Aging
  27. Granulin in Frontotemporal Lobar Degeneration: Molecular Mechanisms of the Disease
    Zemfira N. Karamysheva, Elena B. Tikhonova, Andrey L. Karamyshev · 2019 · Frontiers in Neuroscience
  28. BAG3 Regulation of RAB35 Mediates the Endosomal Sorting Complexes Required for Transport/Endolysosome Pathway and Tau Clearance
    Heng Lin, Maoping Tang, Changyi Ji, Peter Girardi, Gregor Cvetojevic, Daniel Chen, Shon A. Koren, Gail V.W. Johnson · 2021 · Biological Psychiatry
  29. Genetic testing in familial AD and FTD: Mutation and phenotype spectrum in a Danish cohort
    Suzanne Granhøj Lindquist, M. Schwartz, Mustafa Batbayli, Gunhild Waldemar, JE Nielsen · 2009 · Clinical Genetics
  30. New Genes, New Dilemmas: FTLD Genetics and Its Implications for Families
    Jill S. Goldman, Jennifer L. Adamson, Anna Karydas, Bruce L. Miller, Mike Hutton · 2007 · American Journal of Alzheimer s Disease & Other Dementias®
  31. Progranulin and frontotemporal lobar degeneration
    Stuart M. Pickering-Brown · 2007 · Acta Neuropathologica
  32. C9ORF72 hexanucleotide repeats in behavioral and motor neuron disease: clinical heterogeneity and pathological diversity.
    Jennifer S. Yokoyama, Daniel W. Sirkis, Bruce L. Miller · 2014 · Europe PMC (PubMed Central)
  33. Modeling ALS and FTLD proteinopathies in yeast: An efficient approach for studying protein aggregation and toxicity
    Dmitry S. Kryndushkin, Frank P. Shewmaker · 2011 · Prion
  34. Frontotemporal dementia spectrum: first genetic screen in a Greek cohort
    Eliana Marisa Ramos, Christos Koros, Deepika Reddy Dokuru, Victoria Van Berlo, Christos Κroupis, Kevin J. Wojta, Qing Wang, Nikolaos Andronas, Stavroula Matsi, Ion Beratis et al. · 2018 · Neurobiology of Aging
  35. Genetic Testing for Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
    Jennifer Roggenbuck, Jamie C Fong · 2020 · Clinics in Laboratory Medicine
  36. Neuroprotective activity of ursodeoxycholic acid in CHMP2B models of frontotemporal dementia
    Ryan J. H. West, Chris Ugbode, Laura Fort‐Aznar, Sean T. Sweeney · 2020 · Neurobiology of Disease
  37. Pathogenic Single Nucleotide Polymorphisms on Autophagy-Related Genes
    Isaac Tamargo‐Gómez, Álvaro F. Fernández, Guillermo Mariño · 2020 · International Journal of Molecular Sciences
  38. PIKfyve mediates the motility of late endosomes and lysosomes in neuronal dendrites
    Fuminori Tsuruta, Ricardo E. Dolmetsch · 2015 · Neuroscience Letters
  39. Frontotemporal Dementia: From Mendelian Genetics Towards Genome Wide Association Studies
    Raffaele Ferrari, John Hardy, Parastoo Momeni · 2011 · Journal of Molecular Neuroscience
  40. Proteomic Analysis of Hippocampal Dentate Granule Cells in Frontotemporal Lobar Degeneration: Application of Laser Capture Technology
    Yair M. Gozal, Eric B. Dammer, Duc Minh Duong, Dongmei Cheng, Marla Gearing, Howard D. Rees, Junmin Peng, James J. Lah, Allan I. Levey · 2011 · Frontiers in Neurology
  41. Prevalence of frontotemporal lobar degeneration in an isolated population: the Vallecamonica study
    Nicola Gilberti, Marinella Turla, Antonella Alberici, Valeria Bertasi, Patrizia Civelli, Silvana Archetti, Alessandro Padovani, Barbara Borroni · 2011 · Neurological Sciences
  42. Component Interaction of ESCRT Complexes Is Essential for Endocytosis-Dependent Growth, Reproduction, DON Production and Full Virulence in Fusarium graminearum
    Qiurong Xie, Ahai Chen, Yunzhi Zhang, Mingyue Yuan, Wei Xie, Chengkang Zhang, Wenhui Zheng, Zonghua Wang, Guangpu Li, Jie Zhou · 2019 · Frontiers in Microbiology
  43. Motor and Sensory Deficits in the teetering Mice Result from Mutation of the ESCRT Component HGS
    Jennifer A. Watson, Bula J. Bhattacharyya, Jada H. Vaden, Julie A. Wilson, Mert Icyuz, Alan D. Howard, Edward Phillips, Tara M. DeSilva, Gene P. Siegal, Andrew J. Bean et al. · 2015 · PLoS Genetics
  44. ESCRT proteins, endosome organization and mitogenic receptor down-regulation
    Philip G. Woodman · 2009 · Biochemical Society Transactions
  45. The many ways to frontotemporal degeneration and beyond
    Orso Bugiani · 2007 · Neurological Sciences
  46. Toward precision medicine in amyotrophic lateral sclerosis.
    Zhang‐Yu Zou, Chang-Yun Liu, Chun‐Hui Che, Huapin Huang · 2016 · PubMed Central
  47. Frontotemporal Lobar Degeneration with Ubiquitin-Positive Inclusions: A Molecular Genetic Update
    Julie van der Zee, Ilse Gijselinck, Daniel Nicolae Pirici, Samir Kumar‐Singh, Marc Cruts, Christine Van Broeckhoven · 2007 · Neurodegenerative Diseases
  48. Pathway from TDP-43-Related Pathology to Neuronal Dysfunction in Amyotrophic Lateral Sclerosis and Frontotemporal Lobar Degeneration
    Yuichi Riku, Danielle Seilhean, Charles J. Duyckaerts, Susana Boluda, Yohei Iguchi, Shinsuke Ishigaki, Yasushi Iwasaki, Mari Yoshida, Gen Sobue, Masahisa Katsuno · 2021 · International Journal of Molecular Sciences
  49. The landscape of cognitive impairment in superoxide dismutase 1-amyotrophic lateral sclerosis
    Ilaria Martinelli, Elisabetta Zucchi, Cecilia Simonini, Giulia Gianferrari, Giovanna Zamboni, Marcello Pinti, Jessica Mandrioli · 2022 · Neural Regeneration Research
  50. An ESCRT grommet cooperates with a diffusion barrier to maintain nuclear integrity
    Nicholas R. Ader, Linda Chen, Ivan Vladimirovich Surovtsev, William L. Chadwick, Elisa C. Rodriguez, Megan C. King, C. Patrick Lusk · 2023 · Nature Cell Biology
  51. TDP-43 and frontotemporal dementia
    William T. Hu, Murray Grossman · 2009 · Current Neurology and Neuroscience Reports
  52. Frontotemporal lobar degeneration through loss of progranulin function
    Michel Goedert, M. G. Spillantini · 2006 · Brain
  53. Genetic testing in dementia‐A medical genetics perspective
    Aamira J. Huq, Adrienne Sexton, Paul A Lacaze, Colin Louis Masters, Elsdon Storey, Dennis Velakoulis, Paul Andrew James, Ingrid Winship · 2021 · International Journal of Geriatric Psychiatry
  54. Lysosomal TRPML1 Channel: Implications in Cardiovascular and Kidney Diseases
    Guangbi Li, Pin‐Lan Li · 2021 · Advances in experimental medicine and biology
  55. Localization of CHMP2B ‐immunoreactivity in the brainstem of Lewy body disease
    Takashi Kurashige, Tetsuya Takahashi, Yu Yamazaki, Masanori Hiji, Yuishin Izumi, Takemori Yamawaki, Masayasu Matsumoto · 2012 · Neuropathology
  56. Need an ESCRT for autophagosomal maturation?
    Marion Manil-Ségalen, Christophe Lefebvre, Emmanuel Culetto, Renaud Legouis · 2012 · Communicative & Integrative Biology
  57. Presymptomatic Generalized Brain Atrophy in Frontotemporal Dementia Caused by CHMP2B Mutation
    Jonathan Daniel Rohrer, R. Laila Ahsan, Adrian M. Isaacs, Jørgen Erik Nielsen, Leif Østergaard, Rachael I. Scahill, Jason D. Warren, Martin N. Rossor, Nick C. Fox, Peter Johannsen · 2009 · Dementia and Geriatric Cognitive Disorders
  58. Aberrantly regulated proteins in frontotemporal dementia
    Kelly S. Schweitzer, Emily D. Decker, Liping Zhu, Richard E. Miller, Suzanne Samuels Mirra, Salvatore Spina, Bernardino Francesco Ghetti, Mu Wang, Jill R. Murrell · 2006 · Biochemical and Biophysical Research Communications
  59. Neurodegenerative diseases: model organisms, pathology and autophagy
    Shwetha Suresh, Vijaya Verma, Shruthi Sateesh, James Premdoss Clement, Ravi R. Manjithaya · 2018 · Journal of Genetics
  60. Meta-analysis of Genetic Modifiers Reveals Candidate Dysregulated Pathways in Amyotrophic Lateral Sclerosis
    Katherine S. Yanagi, Zhijin J. Wu, Joshua Amaya, Natalie Chapkis, Amanda Duffy, Kaitlyn H. Hajdarovic, Aaron Held, Arjun D. Mathur, Kathryn Russo, Veronica H. Ryan et al. · 2018 · Neuroscience
  61. Genetic forms of frontotemporal lobar degeneration: Current diagnostic approach and new directions in therapeutic strategies
    Leila Sellami, Dario Saracino, Isabelle Le Ber · 2020 · Revue Neurologique
  62. Emerging Connections between Nuclear Pore Complex Homeostasis and ALS
    Sunandini Chandra, C. Patrick Lusk · 2022 · International Journal of Molecular Sciences
  63. ESCRT-III function in membrane fission and repair
    Matteo Burigotto, Jeremy Graham Carlton · 2025 · Nature Reviews Molecular Cell Biology
  64. Alternative mechanisms of Notch activation by partitioning into distinct endosomal domains
    Hideyuki Shimizu, Samira Hosseini-Alghaderi, Simon A. Woodcock, Martín Baron · 2024 · The Journal of Cell Biology
  65. Inflammatory markers of CHMP2B-mediated frontotemporal dementia
    Peter Roos, Marina Rode von Essen, Troels T. Nielsen, Peter Johannsen, Jette Stokholm, Anne Sigaard Bie, Gunhild Waldemar, Anja Hviid Simonsen, Amanda Heslegrave, Henrik Zetterberg et al. · 2018 · Journal of Neuroimmunology
  66. Frontotemporal Dementia and Primary Progressive Aphasia: An Update
    Howard S. Kirshner · 2010 · Current Neurology and Neuroscience Reports
  67. Frontotemporal Lobar Degeneration
    Enrico Premi, Alessandro Padovani, Barbara Borroni · 2012 · Advances in experimental medicine and biology
  68. Reversal of pathology in CHMP2B‐mediated frontotemporal dementia patient cells using RNA interference
    Troels T. Nielsen, Sarah Mizielinska, Lis Hasholt, Adrian M. Isaacs, Jørgen Erik Nielsen · 2012 · The Journal of Gene Medicine
  69. Amyotrophic lateral sclerosis and non-tau frontotemporal lobar degeneration
    Tibor Hortobágyi, Nigel J. Cairns · 2017 · Handbook of clinical neurology
  70. Extended FTLD pedigree segregating a Belgian GRN-null mutation: neuropathological heterogeneity in one family
    Anne Sieben, Sara Van Mossevelde, Eline Wauters, Sebastiaan Engelborghs, Julie van der Zee, Tim Van Langenhove, Patrick Santens, Marleen M. Praet, Paul Boon, Marijke Miatton et al. · 2018 · Alzheimer s Research & Therapy
  71. Mutations in CHMP2B are not a cause of frontotemporal lobar degeneration in Finnish patients
    Anna-Lotta Kaivorinne, Johanna Krüger, Bjarne Udd, Kari Majamaa, Anne Marja Remes · 2010 · European Journal of Neurology
  72. Reduced Tau protein expression is associated with frontotemporal degeneration with progranulin mutation
    Anthony Papegaey, Sabiha Eddarkaoui, Vincent Deramecourt, Francisco-José Fernández-Gómez, Pierre Pantano, Hélène Obriot, Camille Machala, Vincent Anquetil, Agnès Camuzat, Alexis Brice et al. · 2016 · Acta Neuropathologica Communications
  73. Progress in Frontotemporal Dementia Research
    Xinling Wang, Yuedi Shen, Wei Chen · 2012 · American Journal of Alzheimer s Disease & Other Dementias®
  74. Cognitive impairment in the preclinical stage of dementia in FTD-3 CHMP2B mutation carriers: a longitudinal prospective study
    Jette Stokholm, Thomas W. Teasdale, Peter Johannsen, Jørgen Erik Nielsen, Troels T. Nielsen, Adrian M. Isaacs, Jerry M. Brown, Anders Gade · 2012 · Journal of Neurology Neurosurgery & Psychiatry
  75. Ik2/TBK1 and Hook/Dynein, an adaptor complex for early endosome transport, are genetic modifiers of FTD-associated mutant CHMP2B toxicity in Drosophila
    Yubing Lu, Ryan J. H. West, Marine Pons, Sean T. Sweeney, Fen‐Biao Gao · 2020 · Scientific Reports
  76. Alzheimer's disease and related dementias
    John Hardy · 2012 · Cambridge University Press eBooks
  77. Novel MAPT Val75Ala mutation and PSEN2 Arg62Hys in two siblings with frontotemporal dementia
    Maura Gallo, Carmine Tomaino, Gianfranco Puccio, Francesca Frangipane, Sabrina A.M. Curcio, Livia Bernardi, Silvana Geracitano, Maria Anfossi, Maria Mirabelli, Rosanna Colao et al. · 2009 · Neurological Sciences
  78. Heterogeneity in motoneuron disease
    Diether Lambrechts, Wim Robberecht, Peter Carmeliet · 2007 · Trends in Neurosciences
  79. Appearance pattern of TDP-43 in Japanese frontotemporal lobar degeneration with ubiquitin-positive inclusions
    Shinji Higashi, Eizo Iseki, Ryoko Yamamoto, Michiko Minegishi, Hiroaki Hino, Koshiro Fujisawa, Takashi Togo, Omi Katsuse, Hirotake Uchikado, Yoshiko Furukawa et al. · 2007 · Neuroscience Letters
  80. No association of chromatin-modifying protein 2B with sporadic frontotemporal dementia
    Axel Schumacher, Patricia Friedrich, Janine Diehl‐Schmid, Bernd Ibach, Tamara Eisele, Simon Matthew Laws, Hans Förstl, Alexander Kurz, Markus J. Riemenschneider · 2006 · Neurobiology of Aging
  81. Small Extracellular Vesicles in Neurodegenerative Disease: Emerging Roles in Pathogenesis, Biomarker Discovery, and Therapy
    Mousumi Ghosh, Amir‐Hossein Bayat, Damien Daniel Pearse · 2025 · International Journal of Molecular Sciences
  82. α-Synuclein aggregates inhibit ESCRT-III through sequestration and collateral degradation
    Cole S. Sitron, Victoria A. Trinkaus, Ana Galesic, Maximilian Garhammer, Patricia Yuste‐Checa, Ulrich Dransfeld, Dennis Feigenbutz, Jiuchun Zhang, Larysa Ivashko, Irina Dudanova et al. · 2025 · Molecular Cell
  83. Genomic analysis of the endosomal sorting required for transport complex III pathway genes as therapeutic and prognostic biomarkers for endometrial carcinoma
    Ye Yang, Min Wang · 2022 · Translational Cancer Research
  84. Elevated 4R tau contributes to endolysosomal dysfunction and neurodegeneration in VCP-related frontotemporal dementia
    Christy Hung, Rickie Patani · 2023 · Brain
  85. ESCRT-III: a versatile membrane remodeling machinery and its implications in cellular processes and diseases
    Jisoo Park, Jongyoon Kim, Hyungsun Park, Tae‐Wan Kim, Seongju Lee · 2024 · Animal Cells and Systems
  86. Genetic spectrum features and diagnostic accuracy of four plasma biomarkers in 248 Chinese patients with frontotemporal dementia
    Tianyan Xu, Ling Weng, Cong Zhang, Xuewen Xiao, Qijie Yang, Yuan Zhu, Yafang Zhou, Xinxin Liao, Shilin Luo, Junling Wang et al. · 2024 · Alzheimer s & Dementia
  87. Telling the Story of Frontotemporal Dementia by Bibliometric Analysis
    Davide Guido, Gabriella Morandi, Fernando Palluzzi, Barbara Borroni · 2015 · Journal of Alzheimer s Disease
  88. Convergence of Synapses, Endosomes, and Prions in the Biology of Neurodegenerative Diseases
    Gunnar K. Gouras · 2013 · International Journal of Cell Biology
  89. Oligodendroglial deletion of ESCRT‐I component TSG101 causes spongiform encephalopathy
    Will P. Walker, Abby Oehler, Aimee L. Edinger, Kay‐Uwe Wagner, Teresa M. Gunn · 2016 · Biology of the Cell
  90. The pro-apoptotic JNK scaffold POSH/SH3RF1 mediates CHMP2BIntron5-associated toxicity in animal models of frontotemporal dementia
    Ryan J. H. West, Chris Ugbode, Fen‐Biao Gao, Sean T. Sweeney · 2018 · Human Molecular Genetics
  91. Effect of tau-pathology on charged multivesicular body protein 2b (CHMP2B)
    Jiwana Sherin Midani-Kurçak, Maja Dinekov, Behrus Puladi, Thomas Arzberger, Christoph N. Köhler · 2018 · Brain Research
  92. Polarized human cholangiocytes release distinct populations of apical and basolateral small extracellular vesicles
    Brian A. Davies, Leslie A. Morton, John R. Jefferson, Cody N. Rozeveld, Luke C. Doskey, Nicholas F. LaRusso, David J. Katzmann · 2020 · Molecular Biology of the Cell
  93. microRNA‐based predictor for diagnosis of frontotemporal dementia
    Iddo Magen, Nancy‐Sarah Yacovzada, Jason D. Warren, Carolin Heller, Imogen J. Swift, Yoana Bobeva, Andrea Malaspina, Jonathan Daniel Rohrer, Pietro Fratta, Eran Hornstein · 2023 · Neuropathology and Applied Neurobiology
  94. Frontotemporal Dementia
    Andrew Kertesz · 2008 · Cognitive and Behavioral Neurology
  95. Novel Missense Mutation in Charged Multivesicular Body Protein 2B in a Patient With Frontotemporal Dementia
    Raffaele Ferrari, Dimitrios Kapogiannis, Edward D. Huey, Jordan Henry Grafman, John Hardy, Parastoo Momeni · 2010 · Alzheimer Disease & Associated Disorders
  96. Genetic Counseling for Frontotemporal Dementias
    Kimberly A. Quaid · 2011 · Journal of Molecular Neuroscience
  97. Frontotemporal dementia
    Erik D. Roberson · 2006 · Current Neurology and Neuroscience Reports
  98. The role of autophagy in the pathogenesis and treatment of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD)
    Jimmy Beckers, Philip Van Damme · 2025 · Autophagy Reports
  99. Nuclear and degradative functions of the ESCRT-III pathway: implications for neurodegenerative disease
    Olivia Keeley, Alyssa N. Coyne · 2024 · Nucleus
  100. Identification of biological pathways regulated by PGRN and GRN peptide treatments using transcriptome analysis
    Sara J. Rollinson, Kate Young, Janis Bennion Callister, Stuart M. Pickering-Brown · 2016 · European Journal of Neuroscience